HP
Hôpital Saint-Louis (AP-HP) at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Hôpital Saint-Louis (AP-HP) takes part in 4 sessions at ESMO 2026 in Madrid. Its program centres on melanoma and skin cancer in immunocompromised patients, including transplant recipients and people with HIV, and on changing treatment in lymphoma and myeloma. Other sessions cover a TERT-targeting vaccine in newly diagnosed glioblastoma and cancer policy.
| Organization | ESMO 2026 Attendance |
|---|---|
HP Hôpital Saint-Louis (AP-HP) Paris, France | |
Public teaching hospital in Paris, France, part of the AP-HP hospital system and affiliated with Université Paris Cité. | Chair Sat Oct 24 10:15–11:45 Challenging clinical scenarios in melanoma and skin cancers Melanoma & skin cancers Talk Sat Oct 24 10:35–10:55 Immunocompromised patients, including transplant and HIV Melanoma & skin cancers Chair Sun Oct 25 08:30–10:00 Changing paradigms in lymphomas and myeloma Haematological malignancies Talk Sun Oct 25 09:10–09:30 Will targeted therapies replace immuno-chemotherapy in the treatment of follicular lymphoma? Haematological malignancies Abstract Sun Oct 25 11:03–11:13 693O - First-in-humanTERT-targeting nanoaggregate vaccine shows safety and induces intratumoral immune responses in newly diagnosed glioblastoma Sarcoma, CNS, head & neck and rare cancers Talk Tue Oct 27 11:40–12:00 |
Instantly find 20 buyers from Hôpital Saint-Louis (AP-HP)
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction